About Sichuan Huiyu Pharmaceutical Company

The company was founded in 2010 and is a comprehensive R&D driven pharmaceutical enterprise, mainly engaged in R&D, production and sales of anti-tumor and injectable drugs. The company's headquarters and production base are located in the Neijiang National Economic and Technological Development Zone. The R&D center is located in Tianfu International Biocenter, Chengdu, and has subsidiaries in the United States, the United Kingdom and Ireland. It is mainly engaged in R&D, production and domestic and international sales of drugs and complex injectable drugs in the field of tumor treatment. The main products include oxaliplatin, pemetrexed disodium for injection, docetaxel injections, azacitidine, etc. Corporate honors: Advanced platform for scientific and technological innovation work in Sichuan Province, the most growing enterprise in China's pharmaceutical industry in 2021, the 2nd “Huiqiao Xingchuan” Contribution Award - Science and Technology Innovation Award, etc.